Commissioner of health direction to study and report on activities to support innovations in cell and gene therapy to treat rare diseases

Introduced

In Committee

Floor

Crossed Over

Passed

Enacted

Overview Bill text 1 History 5 Sponsors

Apr 7, 2026 · Senate

Author added Miller

Mar 25, 2026 · Senate

Author added Hemmingsen-Jaeger

Mar 23, 2026 · Senate

Author added Rasmusson

Mar 5, 2026 · Senate

Introduction and first reading

Mar 5, 2026 · Senate

Referred to Health and Human Services

PASSAGE PROBABILITY

1% Unlikely

Why this number

Stage base In Committee — base rate 2%, measured from MN's completed sessions
Momentum -3 36/100 from the pace of recorded action
Time since last action -22 188 days quiet

A transparent scoring model over stage, momentum, recency, sponsorship and recorded votes — not a trained predictor. Treat it as a way to rank attention, not as a forecast.